LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

LLY

1,008.98

-0.15%↓

JNJ

201.79

-0.2%↓

ABBV

226.23

-1.07%↓

UNH

330.51

-0.85%↓

AZN

90.18

+0.23%↑

Inicio・Lista de Acciones・Avita Therapeutics Inc

Avita Therapeutics Inc

Cerrado

3.48 -1.69

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

3.4699999999999998

Máximo

3.51

Métricas clave
By Trading Economics
Ingresos	-3.3M -13M
Ventas	-1.4M 17M
BPA	-0.712
Margen de beneficio	-77.289
Empleados	260
EBITDA	4M -8.1M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 meses	+85.71% upside

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	-12M 109M
Apertura anterior	5.17
Cierre anterior	3.48

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

8.83 / 9.77 Soporte y Resistencia

Avita Therapeutics Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

7 dic 2025, 23:00 UTC

Adquisiciones, fusiones, absorciones

Brookfield, GIC Agree $4.5 Billion Deal for Australia's National Storage -- Update

5 dic 2025, 21:08 UTC

Adquisiciones, fusiones, absorciones

Meta Platforms Buys AI-Device Maker Limitless

5 dic 2025, 19:39 UTC

Principales Movimientos del Mercado

Parsons' FAA Bid Loss Clouds Outlook After Rocky Year for Contractors

5 dic 2025, 19:17 UTC

Adquisiciones, fusiones, absorciones

Constellation Energy Agrees to Divest Assets to Finalize Calpine Deal

7 dic 2025, 23:42 UTC

Charlas de Mercado

Nikkei May Rise on Weaker Yen -- Market Talk

7 dic 2025, 23:05 UTC

Charlas de Mercado

RBA Set to Remain 'Emphatically' On Hold, Westpac Says -- Market Talk

7 dic 2025, 22:18 UTC

Charlas de Mercado

RBA Set To Conclude Year With Hawkish Message -- Market Talk

6 dic 2025, 16:52 UTC

Adquisiciones, fusiones, absorciones

As Netflix Swoops In to Buy Warner Bros., We Revisit the Studio's Long, Twisted Journey -- Barrons.com

6 dic 2025, 10:30 UTC

Adquisiciones, fusiones, absorciones

Why Netflix Shareholders Aren't Thrilled to Acquire Warner Bros. -- Heard on the Street -- WSJ

6 dic 2025, 02:38 UTC

Adquisiciones, fusiones, absorciones

How a Netflix-Warner Deal Would Change Everything in Hollywood -- Again -- WSJ

5 dic 2025, 21:59 UTC

Adquisiciones, fusiones, absorciones

Netflix's Megadeal Will Need the Trump Administration's Blessing -- Update

5 dic 2025, 21:50 UTC

Charlas de Mercado

Ganancias

Financial Services Roundup: Market Talk

5 dic 2025, 21:50 UTC

Adquisiciones, fusiones, absorciones

The Netflix and Warner Bros. Deal Is Far From a Sure Thing -- Barrons.com

5 dic 2025, 21:36 UTC

Charlas de Mercado

Return of Shipping to Red Sea a Step Closer, Xeneta Says -- Market Talk

5 dic 2025, 21:35 UTC

Adquisiciones, fusiones, absorciones

The Netflix-Warner Bros. Deal Has a Wildcard. How Paramount Could Still Win. -- Barrons.com

5 dic 2025, 21:26 UTC

Adquisiciones, fusiones, absorciones

Warner Bros. Discovery and Netflix Enter Exclusive Deal Negotiations -- 7th Update

5 dic 2025, 21:12 UTC

Charlas de Mercado

Natural Gas Surge 9% This Week on Strong Flow of Exports -- Market Talk

5 dic 2025, 21:03 UTC

Charlas de Mercado

Ganancias

Bank of Montreal Logs Solid Quarter, Though Some Unease Remains -- Market Talk

5 dic 2025, 21:01 UTC

Charlas de Mercado

Oil Caps Positive Week on Geopolitical Turmoil -- Market Talk

5 dic 2025, 20:43 UTC

Adquisiciones, fusiones, absorciones

Limitless CEO Siroker: Will No Longer Sell Pendant to New Customers

5 dic 2025, 20:43 UTC

Adquisiciones, fusiones, absorciones

Limitless CEO Siroker: Existing Pendant Customers to Be Supported for at Least Another Year

5 dic 2025, 20:42 UTC

Adquisiciones, fusiones, absorciones

Limitless CEO Dan Siroker: Limitless Has Been Acquired by Meta >META

5 dic 2025, 20:01 UTC

Adquisiciones, fusiones, absorciones

Netflix Landed a Big Deal. Now it Could Have a Big Fight. -- WSJ

5 dic 2025, 19:44 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

5 dic 2025, 19:44 UTC

Charlas de Mercado

Canada Dollar Gains Nearly 1% on Jobs Data, Rate Outlook -- Market Talk

5 dic 2025, 19:39 UTC

Charlas de Mercado

Silver Climbs to a New Record High -- Market Talk

5 dic 2025, 19:31 UTC

Adquisiciones, fusiones, absorciones

Netflix Stock Falls. Wall Street Is Worried About Warner Deal's High Price and Debt. -- Barrons.com

5 dic 2025, 18:30 UTC

Charlas de Mercado

Canada Jobless Rate Can Fall More Before Labor Slack Disappears -- Market Talk

5 dic 2025, 18:28 UTC

Adquisiciones, fusiones, absorciones

Netflix Stock Falls. Wall Street Is Worried About Warner Deal's High Price and Debt. -- Barrons.com

5 dic 2025, 18:24 UTC

Adquisiciones, fusiones, absorciones

AMC and IMAX Stocks Drop. Roku Rises. How the Netflix-Warner Bros. Deal Could Shake Up Entertainment. -- Barrons.com

Comparación entre iguales

Cambio de precio

Avita Therapeutics Inc Esperado

Precio Objetivo

By TipRanks

85.71% repunte

Estimación a 12 meses

Media 6.5 USD 85.71%

Máximo 11 USD

Mínimo 3 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Avita Therapeutics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

4 ratings

Comprar

Mantener

Vender

De acuerdo con 4 analistas que ofrecen calificaciones bursátiles a para Avita Therapeutics Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

8.83 / 9.77Soporte y Resistencia

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Avita Therapeutics Inc

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.